152 related articles for article (PubMed ID: 15213853)
1. Formation of tissue factor-bearing leukocytes during and after cardiopulmonary bypass.
Shibamiya A; Tabuchi N; Chung J; Sunamori M; Koyama T
Thromb Haemost; 2004 Jul; 92(1):124-31. PubMed ID: 15213853
[TBL] [Abstract][Full Text] [Related]
2. Identification of tissue factor and platelet-derived particles on leukocytes during cardiopulmonary bypass by flow cytometry and immunoelectron microscopy.
Chung J; Suzuki H; Tabuchi N; Sato K; Shibamiya A; Koyama T
Thromb Haemost; 2007 Aug; 98(2):368-74. PubMed ID: 17721619
[TBL] [Abstract][Full Text] [Related]
3. Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation.
Zillmann A; Luther T; Müller I; Kotzsch M; Spannagl M; Kauke T; Oelschlägel U; Zahler S; Engelmann B
Biochem Biophys Res Commun; 2001 Feb; 281(2):603-9. PubMed ID: 11181090
[TBL] [Abstract][Full Text] [Related]
4. Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass.
Chung JH; Gikakis N; Rao AK; Drake TA; Colman RW; Edmunds LH
Circulation; 1996 Jun; 93(11):2014-8. PubMed ID: 8640976
[TBL] [Abstract][Full Text] [Related]
5. The GPIIb/IIIa antagonist eptifibatide markedly potentiates platelet-leukocyte interaction and tissue factor expression following platelet activation in whole blood in vitro.
Scholz T; Zhao L; Temmler U; Bath P; Heptinstall S; Lösche W
Platelets; 2002 Nov; 13(7):401-6. PubMed ID: 12487787
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor in patients with acute coronary syndromes: expression in platelets, leukocytes, and platelet-leukocyte aggregates.
Brambilla M; Camera M; Colnago D; Marenzi G; De Metrio M; Giesen PL; Balduini A; Veglia F; Gertow K; Biglioli P; Tremoli E
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):947-53. PubMed ID: 18292391
[TBL] [Abstract][Full Text] [Related]
7. Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds.
Hattori T; Khan MM; Colman RW; Edmunds LH
J Am Coll Cardiol; 2005 Aug; 46(4):707-13. PubMed ID: 16098440
[TBL] [Abstract][Full Text] [Related]
8. [Tissue factor expression of platelets and leukocytes in patients with acute coronary syndromes].
Lu HY; Chen D; Gu J; Song LX; Chen M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):678-83. PubMed ID: 23815921
[TBL] [Abstract][Full Text] [Related]
9. P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonist.
Zhao L; Bath PM; May J; Lösche W; Heptinstall S
Platelets; 2003; 14(7-8):473-80. PubMed ID: 14713516
[TBL] [Abstract][Full Text] [Related]
10. Transfer of tissue factor from platelets to monocytes: role of platelet-derived microvesicles and CD62P.
Scholz T; Temmler U; Krause S; Heptinstall S; Lösche W
Thromb Haemost; 2002 Dec; 88(6):1033-8. PubMed ID: 12529756
[TBL] [Abstract][Full Text] [Related]
11. Effect of glycoprotein IIb/IIIa antagonist abciximab on monocyte-platelet aggregates and tissue factor expression.
Steiner S; Seidinger D; Huber K; Kaun C; Minar E; Kopp CW
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1697-702. PubMed ID: 12869353
[TBL] [Abstract][Full Text] [Related]
12. Platelet-derived microvesicles transfer tissue factor to monocytes but not to neutrophils.
Lösche W; Scholz T; Temmler U; Oberle V; Claus RA
Platelets; 2004 Mar; 15(2):109-15. PubMed ID: 15154603
[TBL] [Abstract][Full Text] [Related]
13. Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: a clinical study.
Ernofsson M; Thelin S; Siegbahn A
J Thorac Cardiovasc Surg; 1997 Mar; 113(3):576-84. PubMed ID: 9081105
[TBL] [Abstract][Full Text] [Related]
14. Tissue factor messenger RNA levels in leukocytes compared with tissue factor antigens in plasma from patients in hypercoagulable state caused by various diseases.
Sase T; Wada H; Kamikura Y; Kaneko T; Abe Y; Nishioka J; Nobori T; Shiku H
Thromb Haemost; 2004 Jul; 92(1):132-9. PubMed ID: 15213854
[TBL] [Abstract][Full Text] [Related]
15. Intravascular tissue factor pathway--a model for rapid initiation of coagulation within the blood vessel.
Engelmann B; Luther T; Müller I
Thromb Haemost; 2003 Jan; 89(1):3-8. PubMed ID: 12540946
[TBL] [Abstract][Full Text] [Related]
16. Tissue factor is rapidly elevated in plasma collected from the pericardial cavity during cardiopulmonary bypass.
Philippou H; Adami A; Davidson SJ; Pepper JR; Burman JF; Lane DA
Thromb Haemost; 2000 Jul; 84(1):124-8. PubMed ID: 10928482
[TBL] [Abstract][Full Text] [Related]
17. Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome.
Ståhl AL; Sartz L; Nelsson A; Békássy ZD; Karpman D
PLoS One; 2009 Sep; 4(9):e6990. PubMed ID: 19750223
[TBL] [Abstract][Full Text] [Related]
18. Effects of the pan-selectin antagonist bimosiamose (TBC1269) in experimental human endotoxemia.
Mayr FB; Firbas C; Leitner JM; Spiel AO; Reiter RA; Beyer D; Meyer M; Wolff G; Jilma B
Shock; 2008 Apr; 29(4):475-82. PubMed ID: 18598003
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of somatostatin on circulating tissue factor procoagulant activity and protein.
Boden G; Vaidyula V; Homko C; Mozzoli M; Rao AK
Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1333-9. PubMed ID: 17213471
[TBL] [Abstract][Full Text] [Related]
20. The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation.
Straub A; Wendel HP; Azevedo R; Ziemer G
Eur J Cardiothorac Surg; 2005 Apr; 27(4):617-21. PubMed ID: 15784360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
